IVA Webinar | Developing a Standardised Integrative Nutraceutical for Splenic Hemangiosarcoma | Dr Matt Muir
Canine splenic hemangiosarcoma remains a major therapeutic challenge. This presentation reviews conventional and emerging integrative evidence, then traces the development of a standardised, multi-target nutraceutical, from clinical observations and biological rationale through a clinical experience program toward prospective investigation
1 CPD Point